[1] 樊红平,侯水生.家禽体内脂肪沉积调控的研究进展[J].动物营养学报,2004,16(4):1-6.
[2] 吴自光,刘相玉.影响乳脂的因素及提高乳脂率的方法[J].山东农业科学,2004,6:54-55.
[3] 季海峰,张沅.猪脂肪代谢的研究进展[J].中国畜牧杂志,1993,29(3):59-61.
[4] ALBERTI K G,ZIMMET P,SHAW J.Metabolic syndrome:a new world-wide definition.A consensus statement from the international diabetes federation[J].Diabetic Medicine,2006,23(5):469-480.
[5] TERAN-GARCIA M,BOUCHARD C.Genetics of the metabolic syndrome[J].Applied Physiology Nutrition and Metabolism,2007,32:89-114.
[6] BARTEL D P.MicroRNAs:genomics,biogenesis,mechanism and function[J].Cell,2004,116(2):281-297.
[7] BRENNECKE J,STARK A,RUSSELL R B,et al.Principles of microRNA-target recognition[J].PLoS Biology,2005,3(3):e85.
[8] KREK A,GRUN D,POY M N,et al.Combinatorial microRNA target predictions[J].Nature Genetics,2005,37(5):495-500.
[9] DOENCH J G,SHARP P A.Specificity of microRNA target selection in translational repression[J].Genes and Development,2004,18(5):504-511.
[10] 李龙江,余瑜.脂代谢的信号转导途径[J].儿科药学杂志,2005,11(1):7-9.
[11] BERGER J,LEIBOWITZ M D,DOEBBER T W,et al.Novel peroxisome proliferator activated receptors (PPAR)γ and PPARδ ligands produce distinct biological effects[J].Journal of Biological Chemistry,1999,274:6178-6725.
[12] LEE C H,OLSON P,EVANS R M.Mini-review:lipid metabolism,metabolic diseases and peroxisome proliferator activated receptors[J].Endocrinology,2003,144(6):2201-2207.
[13] BOITIER E,GAUTIER J C,ROBERTS R.Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models:relevance for human health and disease[J].Comparative Hepatology,2003,2(1):3-17.
[14] CHAWLA A,LEE C H,BARAK Y,et al.PPAR delta is a very low density lipoprotein sensor in macrophages[J].Proceedings of the National Academy of Sciences of the United States of America,2003,100(3):1268-1273.
[15] HORTON J D,GOLDSTEIN J L,BROWN M S.SREBPs:activators of the complete program of cholesterol and fatty acid synthesis in the liver[J].Journal of Clinical Investigation,2002,109:1125-1131.
[16] BROWN M S,GOLDSTEIN J L.The SREBP pathway:regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor[J].Cell,1997,89:331-340.
[17] OSBORNE T F.Sterol regulatory element-binding proteins (SREBPs):key regulators of nutritional homeostasis and insulin action[J].Journal of Biological Chemistry,2000,275:32379-32382.
[18] PEET D J,JANOWSKI B A,MANGELSDORF D J.The LXRs:a new class of oxysterol receptors[J].Current Opinion in Genetics and Development,1998,8(5):571-575.
[19] TONTONOZ P,MANGELSDORF D J.Liver X receptor signaling pathways in cardiovascular disease[J].Molecular Endocrinology,2003,17:985-993.
[20] BRADLEY M N,HONG C,CHEN M,et al.Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE[J].Journal of Clinical Investigation,2007,117:2337-2346.
[21] CLAUDEL T,LEIBOWITZ M D,FIEVET C,et al.Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor[J].Proceedings of the National Academy of Sciences of the United States of America,2001,98(5):2610-2615.
[22] JOSEPH S B,MCKILLIGIN E,PEI L,et al.Synthetic LXR ligand inhibits the development of atherosclerosis in mice[J].Proceedings of the National Academy of Sciences of the United States of America,2002,99:7604-7609.
[23] REPA J J,LIANG G,OU J,et al.Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors LXR-alpha and LXR-beta[J].Genes and Development,2000,14:2819-2830.
[24] PEET D J,TURLEY S D,MA W,et al.Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR-alpha[J].Cell,1998,93(5):693-704.
[25] CHEN G,LIANG G,OU J,et al.Central role for liver X receptor in insulin-mediated activation of SREBP-1C transcription and stimulation of fatty acid synthesis in liver[J].Proceedings of the National Academy of Sciences of the United States of America,2004,101:11245-11250.
[26] OTA A,TAGAWA H,KARNAN S,et al.Identification and characterization of a novel gene,C13orf25,as a target for 13q31-q32 amplification in malignant lymphoma[J].Cancer Research,2004,64(9):3087-3095.
[27] LEE R C,FEINBAUM R L,AMBROS V.The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J].Cell,1993,75:843-854.
[28] RODRIGUEZ A,GRIFFITHS J S,ASHURST J L,et al.Identification of mammalian microRNA host genes and transcription units[J].Genome Research,2004,14:1902-1910.
[29] LEE Y,AHN C,HAN J,et al.The nuclear RNase Ⅲ Drosha initiates microRNA processing[J].Nature,2003,425:415-419.
[30] LEE Y,JEON K,LEE J T,et al.MicroRNA maturation:stepwise processing and subcellular localization[J].The EMBO Journal,2002,21:4663-4670.
[31] BERNSTEIN E,CAUDY A A,HAMMOND S M,et al.Role for abidentate ribonuclease in the initiation step of RNA interference[J].Nature,2001,409:363-366.
[32] YEOM K H,LEE Y,HAN J,et al.Characterization of DGCR8/Pasha,the essential cofactor for Drosha in primary miRNA processing[J].Nucleic Acids Research,2006,34:4622-4629.
[33] LIU J,CARMELL M A,RIVAS F V,et al.Argonaute 2 is the catalytic engine of mammalian RNAi[J].Science,2004,305:1437-1441.
[34] HAMMOND S M,BERNSTEIN E,BEACH D,et al.An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells[J].Nature,2000,404:293-296.
[35] LIU J,VALENCIA-SANCHEZ M A,HANNON G J,et al.MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies[J].Nature Cell Biology,2005,7:719-723.
[36] LAI E C.MicroRNAs are complementary to 3'UTR sequence motifs that mediate negative post-transcriptional regulation[J].Nature Genetics,2002,30:363-364.
[37] SAXENA S,JONSSON Z O,DUTTA A.Small RNAs with imperfect match to end ogenous mRNA repress translation.Implications for off-target activity of small inhibitory RNA in mammalian cells[J].Journal of Biological Chemistry,2003,278:44312-44319.
[38] NAJAFI-SHOUSHTARI S H,FJORALBA K,LI Y X,et al.MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis[J].Science,2010,328:1566-1569.
[39] RAYNER K J,SHEEDY F J,ESAU C C.Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis[J].Journal of Clinical Investigation,2011,121(7):2921-2931.
[40] RAYNER K J,SUAREZ Y,DAVALOS A,et al.MiR-33 contributes to the regulation of cholesterol homeostasis[J].Science,2010,328:1570-1573.
[41] RAYNER K J,ESAU C C,HUSSAIN F N,et al.Inhibition of miR-33a/b in non-human primates raises plasma HDL and reduces VLDL triglycerides[J].Nature,2012,478:404-407.
[42] TSAI W C,HSU S D,HSU C S,et al.MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis[J].Journal of Clinical Investigation,2012,122(8):2773-2897.
[43] CHANG J,NICOLAS E,MARKS D,et al.miR-122,a mammalian liver-specific microRNA,is processed from hcr mRNA and may down-regulate the high affinity cationic amino acid transporter CAT-1[J].RNA Biology,2004,1:106-113.
[44] ESAU C,DAVIS S,MURRAY S F,et al.miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting[J].Cell Metabolism,2006,3(2):87-98.
[45] KOJIMA S,GATFIELD D,ESAU C C,et al.MicroRNA-122 modulates the rhythmic expression profile of the circadian deadenylase nocturnin in mouse liver[J].PLoS One,2010,5(6):e11264.
[46] ELMÉN J,LINDOW M,SILAHTAROGLU A,et al.Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to upregulation of a large set of predicted target mRNAs in the liver[J].Nucleic Acids Research,2008,36:1153-1162.
[47] CHEN W J,YIN K,ZHAO G J,et al.The magic and mystery of microRNA-27 in atherosclerosis[J].Atherosclerosis.2012,222(2):314-323.
[48] KIM S Y,KIM A Y,LEE H W,et al.miR-27a is a negative regulator of adipocyte differentiation via suppressing PPAR-γ expression[J].Biochemical and Biophysical Research Communications,2010,392:323-328.
[49] KARBIENER M,FISCHER C,NOWITSCH S,et al.MicroRNA miR-27b impairs human adipocyte differentiation and targets PPAR gamma[J].Biochemical and Biophysical Research Communications,2009,390:247-251.
[50] KIDA K,NAKAJIMA M,MOHRI T,et al.PPAR alpha is regulated by miR-21 and miR-27b in human liver[J].Pharmaceutical Research,2011,28:2467-2476.
[51] WANG T,LI M Z,GUAN J Q,et al.MicroRNAs miR-27a and miR-143 regulate porcine adipocyte lipid metabolism[J].International Journal of Molecular Sciences,2011,12:7950-7959.
[52] NAKANISHI N,NAKAGAWA Y,TOKUSHIGE N,et al.The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice[J].Biochemical and Biophysical Research Communications,2009,385:492-496.
[53] GERIN I,BOMMER G T,MCCOIN C S,et al.Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis[J].American Journal of Physiology-endocrinology and Metabolism,2010,299:198-206.
[54] VINCIGUERRA M,SGROI A,VEYRAT-DUREBEX C,et al.Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes[J].Hepatology,2009,49(4):1176-1184.
[55] ESAU C,KANG X L,PERALTA E,et al.MicroRNA-143 regulates adipocyte differentiation[J].Journal of Biological Chemistry,2004,279(50):52361-52365.
